Bradykinin receptor 2 antagonist (icatibant) for hereditary angioedema type III attacks.
Bouillet
Laurence
L
Boccon-Gibod
Isabelle
I
Ponard
Denise
D
Drouet
Christian
C
Cesbron
Jean Yves
JY
Dumestre-Perard
Chantal
C
Monnier
Nicole
N
Lunardi
Joel
J
Massot
Christian
C
Gompel
Anne
A
D000319:Adrenergic beta-Antagonists / Q000008:administration & dosage / Q000627:therapeutic use*; D000328:Adult; D001920:Bradykinin / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000627:therapeutic use; D065168:Bradykinin Receptor Antagonists; D050718:Complement C1 Inhibitor Protein / Q000235:genetics; D005260:Female; D017353:Gene Deletion; D056828:Hereditary Angioedema Type III / Q000188:drug therapy* / Q000235:genetics; D006801:Humans; D007279:Injections, Subcutaneous; D016896:Treatment Outcome
D000319:Adrenergic beta-Antagonists; D065168:Bradykinin Receptor Antagonists; D050718:Complement C1 Inhibitor Protein; C065679:icatibant; D001920:Bradykinin